Want to see SE:CI full AI Analyst Report?
CI Stock Chart & Stats
kr0.07
>-kr0.01(-1.46%)
At close: 4:00 PM EDT
kr0.07
>-kr0.01(-1.46%)
Day’s Range― - ―
52-Week Rangekr0.03 - kr0.46
Previous CloseN/A
Volume375.80K
Average Volume (3M)4.19M
Market Cap
kr42.46M
Enterprise Valuekr52.17
Total Cash (Recent Filing)kr424.00K
Total Debt (Recent Filing)kr13.91M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding1,326,965,700
10 Day Avg. Volume5,085,512
30 Day Avg. Volume4,185,927
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.27
Price to Sales (P/S)5.83
P/FCF Ratio-0.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.42
Revenue Forecast (FY)kr17.00M
Bulls Say, Bears Say
Bulls Say
Proprietary Forming TechnologyProprietary high-velocity forming technology positions Cell Impact in a specialized part of the hydrogen equipment chain. If customers scale fuel-cell and electrolyzer manufacturing, this technology and production-system focus can support repeatable industrialization demand over several quarters.
Modest LeverageTTM debt-to-equity of about 0.12 and meaningfully lower total debt versus 2025 reduce immediate balance-sheet pressure. This gives the company more flexibility than a highly leveraged business while it works through losses, although it does not remove funding needs.
Multiple Revenue StreamsEquipment sales are complemented by installation, commissioning, engineering, aftermarket services, and customer-specific development or industrialization projects. This broader offering can deepen customer relationships and create service and project revenue alongside major production-line orders.
Bears Say
Persistent UnprofitabilityNegative gross profit combined with very large operating and net losses indicates that the current business model is not covering its cost base. Unless pricing, utilization, or operating efficiency improves, ongoing losses can weaken equity and constrain investment in future growth.
Shrinking RevenueDeclining revenue points to weakening demand or customer volumes at a time when the company is already reporting negative gross profit. A sustained contraction would reduce operating leverage, make fixed costs harder to absorb, and delay the path toward commercially sustainable earnings.
Persistent Cash BurnConsistently negative operating and free cash flow show that Cell Impact is not funding operations internally. Continued cash burn raises the likelihood of additional financing, dilution, or refinancing needs and can limit the company’s ability to fund production-system development.
CI FAQ
What was Cell Impact AB’s price range in the past 12 months?
Cell Impact AB lowest stock price was kr0.03 and its highest was kr0.46 in the past 12 months.
What is Cell Impact AB’s market cap?
Cell Impact AB’s market cap is kr42.46M.
When is Cell Impact AB’s upcoming earnings report date?
Cell Impact AB’s upcoming earnings report date is Nov 06, 2026 which is in 48 days.
How were Cell Impact AB’s earnings last quarter?
Cell Impact AB released its earnings results on Aug 05, 2026. The company reported -kr0.031 earnings per share for the quarter.
Is Cell Impact AB overvalued?
According to Wall Street analysts Cell Impact AB’s price is currently Overvalued.
Does Cell Impact AB pay dividends?
Cell Impact AB does not currently pay dividends.
What is Cell Impact AB’s EPS estimate?
Cell Impact AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cell Impact AB have?
Cell Impact AB has 1,326,965,700 shares outstanding.
What happened to Cell Impact AB’s price movement after its last earnings report?
Cell Impact AB reported an EPS of -kr0.031 in its last earnings report. Following the earnings report the stock price went down -2.857%.
Which hedge fund is a major shareholder of Cell Impact AB?
Currently, no hedge funds are holding shares in SE:CI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cell Impact AB
Cell Impact AB (publ) is a Swedish firm that specializes in the global production and distribution of bipolar flow plates, which are crucial components for hydrogen fuel cells. The company's products include plates designed with meticulously precise flow patterns, primarily serving manufacturers within the hydrogen fuel cell industry. Founded in 1999, its headquarters are located in Karlskoga, Sweden.
Technical Analysis
SciBase Holding AB
―
Annexin Pharmaceuticals AB
―
OssDsign AB
―
Corline Biomedical AB
―
FluoGuide A/S
―